Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention
Top Cited Papers
- 28 February 2011
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 4 (2) , 191-197
- https://doi.org/10.1016/j.jcin.2010.10.011
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The clinical significance of hematocrit values before and after percutaneous coronary interventionAmerican Heart Journal, 2009
- Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromesEuropean Heart Journal, 2009
- Transradial Intervention for Minimizing Bleeding Complications in Percutaneous Coronary InterventionThe American Journal of Cardiology, 2009
- Bleeding, Blood Transfusion, and Increased Mortality After Percutaneous Coronary InterventionJournal of the American College of Cardiology, 2009
- Determining the In‐Hospital Cost of Bleeding in Patients Undergoing Percutaneous Coronary InterventionJournal of Interventional Cardiology, 2009
- Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trialEuropean Heart Journal, 2009
- Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromesEuropean Heart Journal, 2008
- Bivalirudin for Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2006
- Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary InterventionNew England Journal of Medicine, 2006
- Comparison of Fondaparinux and Enoxaparin in Acute Coronary SyndromesNew England Journal of Medicine, 2006